HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xianlin Han Selected Research

Hyperlipidemias (Hyperlipidemia)

11/2020Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes.
2/2005Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xianlin Han Research Topics

Disease

44Alzheimer Disease (Alzheimer's Disease)
09/2023 - 08/2002
26Insulin Resistance
11/2023 - 03/2003
21Obesity
11/2023 - 12/2006
18Neoplasms (Cancer)
05/2024 - 12/2008
17Mitochondrial Diseases (Mitochondrial Disease)
10/2023 - 12/2005
15Inflammation (Inflammations)
04/2024 - 08/2010
12Cognitive Dysfunction
08/2023 - 12/2009
9Non-alcoholic Fatty Liver Disease
05/2024 - 09/2011
9Cardiomyopathies (Cardiomyopathy)
01/2020 - 01/2002
7Neuroinflammatory Diseases
04/2024 - 12/2010
6Fibrosis (Cirrhosis)
09/2023 - 11/2013
6Dementia (Dementias)
11/2021 - 08/2002
5Barth Syndrome
01/2020 - 11/2013
5Type 2 Diabetes Mellitus (MODY)
01/2020 - 12/2006
5Brain Injuries (Brain Injury)
12/2018 - 03/2003
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016 - 11/2007
5Diabetic Cardiomyopathies
05/2007 - 01/2002
4Weight Gain
11/2023 - 11/2010
4Insulinoma
01/2023 - 06/2018
4Hyperglycemia
01/2022 - 10/2012
4Ischemia
01/2020 - 06/2003
3Liver Diseases (Liver Disease)
11/2023 - 01/2022
3Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021 - 12/2007
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2021 - 12/2016
3Diabetes Mellitus
11/2020 - 01/2002
3Pancreatic Neoplasms (Pancreatic Cancer)
02/2020 - 05/2014
3Cardiomegaly (Heart Hypertrophy)
01/2020 - 02/2003
3Inborn Genetic Diseases (Disease, Hereditary)
01/2020 - 12/2007
3Atrophy
11/2019 - 01/2019
3Disease Progression
01/2017 - 07/2012
3Hypertrophy
11/2013 - 01/2002
2Tauopathies
04/2024 - 02/2024
2Synucleinopathies
02/2024 - 11/2021
2Carcinogenesis
02/2024 - 01/2016
2Fatty Liver
09/2023 - 01/2022
2Body Weight (Weight, Body)
06/2023 - 01/2018
2Multiple Sclerosis
05/2023 - 06/2012
2Demyelinating Diseases (Demyelinating Disease)
05/2023 - 06/2012
2Hypoxia (Hypoxemia)
01/2023 - 03/2019
2Dyslipidemias (Dyslipidemia)
01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

58LipidsIBA
11/2023 - 08/2002
19Glucose (Dextrose)FDA LinkGeneric
11/2023 - 01/2002
19Phospholipids (Phosphatides)FDA LinkGeneric
11/2023 - 06/2003
17Fatty Acids (Saturated Fatty Acids)IBA
05/2024 - 01/2002
17Proteins (Proteins, Gene)FDA Link
03/2024 - 03/2003
15Sulfoglycosphingolipids (Sulfatides)IBA
06/2023 - 08/2002
15Biomarkers (Surrogate Marker)IBA
06/2023 - 07/2003
15Cardiolipins (Cardiolipin)IBA
12/2022 - 12/2005
11Apolipoproteins E (ApoE)IBA
06/2023 - 03/2003
10CeramidesIBA
05/2024 - 08/2002
10Amyloid (Amyloid Fibrils)IBA
08/2023 - 07/2010
10Insulin (Novolin)FDA Link
01/2023 - 11/2010
9EnzymesIBA
01/2023 - 03/2003
7Triglycerides (Triacylglycerol)IBA
01/2022 - 02/2003
6Phosphatidylcholines (Phosphatidylcholine)IBA
11/2023 - 11/2012
6ApolipoproteinsIBA
06/2023 - 06/2010
6Amyloid beta-PeptidesIBA
01/2021 - 01/2004
5RNA (Ribonucleic Acid)IBA
05/2024 - 01/2017
5Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2023 - 01/2017
5CholesterolIBA
01/2023 - 10/2007
5PlasmalogensIBA
11/2020 - 08/2002
5Peptides (Polypeptides)IBA
01/2020 - 08/2008
4LeptinIBA
11/2023 - 01/2020
4Protein Isoforms (Isoforms)IBA
06/2023 - 09/2004
4Acyl Coenzyme A (Acyl CoA)IBA
06/2022 - 09/2005
4Adenosine Triphosphate (ATP)IBA
01/2022 - 07/2008
4DiglyceridesIBA
01/2022 - 11/2010
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2019 - 01/2002
4CalciumIBA
11/2019 - 06/2003
4Calcium-Independent Phospholipases A2IBA
11/2010 - 06/2003
4PPAR alphaIBA
12/2007 - 01/2002
3Carrier Proteins (Binding Protein)IBA
05/2024 - 03/2003
3Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
05/2024 - 06/2003
3phosphatidylethanolamineIBA
03/2024 - 11/2020
3Type C PhospholipasesIBA
03/2024 - 03/2003
3Glucosylceramides (Glucocerebrosides)IBA
02/2024 - 12/2006
3Membrane LipidsIBA
11/2023 - 12/2013
3Nonesterified Fatty Acids (NEFA)IBA
01/2023 - 01/2018
3Blood Glucose (Blood Sugar)IBA
01/2023 - 01/2016
3Arachidonic Acid (Vitamin F)IBA
06/2022 - 12/2021
3arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA
01/2020 - 11/2015
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 01/2014
3Phosphatidylinositols (Phosphatidylinositol)IBA
12/2016 - 07/2003
3Phospholipases (Phospholipase)IBA
11/2010 - 06/2003
3SphingolipidsIBA
01/2009 - 03/2003
2phosphatidylcholine-ceramide phosphocholine transferaseIBA
03/2024 - 09/2023
2Neutralizing AntibodiesIBA
11/2023 - 11/2023
2fibroblast growth factor 21IBA
11/2023 - 11/2023
2Insulin ReceptorIBA
11/2023 - 10/2012
2DNA (Deoxyribonucleic Acid)IBA
08/2023 - 03/2019
2GlycosphingolipidsIBA
05/2023 - 12/2006
2Oxygen (Dioxygen)IBA
01/2023 - 03/2019
2Ligases (Synthetase)IBA
06/2022 - 12/2021
2IronIBA
01/2022 - 07/2011
2Amino AcidsFDA Link
01/2022 - 01/2022
2Messenger RNA (mRNA)IBA
01/2022 - 03/2009

Therapy/Procedure

6Therapeutics
02/2024 - 12/2007
2Pancreatectomy
12/2023 - 11/2020
2Neoadjuvant Therapy
12/2023 - 04/2021
2Length of Stay
09/2023 - 01/2017